Joshua T. Jones - Concepedia

Author

Joshua T. Jones

Also Known As

J Jones, J T Jones, J. Jones, J.T. Jones, Jaden Jones, Joshua Jones, Joshua T Jones, Joshua T. Jones, Joshua Timothy Jones

Publications

Citations

H-Index

Concepts

All Affiliations

Stanford University Myriad Genetics The University of Texas MD Anderson Cancer Center Harvard University Duke Medical Center

About

Joshua T. Jones is an author at Stanford University specializing in medicine, cell biology, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.4K
2	Natural Sciences	5	5	1.1K
3	Engineering	1	1	36
4	Health Sciences	1	1	36
5	Biochemistry	1	1	57

Joshua T. Jones

Publications

4.9K

Citations

H-Index

Page 1

	Year	Citations
STIM Is a Ca2+ Sensor Essential for Ca2+-Store-Depletion-Triggered Ca2+ Influx Jen Liou, Man Lyang Kim, Won Do Heo, Current Biology PhysiologyCa2+ Sensor Essential	2005	2.1K
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Melinda L. Telli, Kirsten M. Timms, Julia Reid, Clinical Cancer Research	2016	1.1K
STIM Is a Ca 2+ Sensor Essential for Ca 2+ -Store-Depletion-Triggered Ca 2+ Influx Jen Liou, Won Do Heo, Joshua T. Jones, Ca 2+Molecular RegulationGene ProductsstimMolecular BiologySensor Essential	2005	330
Efficient Chromosome Capture Requires a Bias in the ‘Search-and-Capture’ Process during Mitotic-Spindle Assembly Roy Wollman, Eric N. Cytrynbaum, Joshua T. Jones, Current Biology ChromatinChromosome DynamicsChromatin StructureCell DivisionCytogenetics	2005	283
Recombinant Dicer efficiently converts large dsRNAs into siRNAs suitable for gene silencing Jason W. Myers, Joshua T. Jones, Tobias Meyer, Nature Biotechnology MedicineGeneticsSirnas SuitableNatural SciencesRna Biology	2003	209
Cyclin A2 Regulates Nuclear-Envelope Breakdown and the Nuclear Accumulation of Cyclin B1 Delquin Gong, Joseph R. Pomerening, Jason W. Myers, Current Biology ChromatinCyclin A2Nuclear StructureCell RegulationNatural Sciences	2007	148
Quantitative analysis of cell cycle phase durations and PC12 differentiation using fluorescent biosensors Angela T. Hahn, Joshua T. Jones, Tobias Meyer Cell Cycle	2009	140
Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated breast cancer Melinda L. Telli, Jessica A. Hellyer, William Audeh, Breast Cancer Research and Treatment Homologous Recombination DeficiencyBreast OncologyMedicineImmunologyPathology	2017	128
Tagging ribozyme reaction sites to follow trans–splicing in mammalian cells Joshua T. Jones, Seong‐Wook Lee, Bruce A. Sullenger Nature Medicine Transcriptional RegulationNatural SciencesRna SplicingRna BiologyMolecular Biology	1996	126
Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579) Virginia Kaklamani, Jacqueline S. Jeruss, Elisha Hughes, Breast Cancer Research and Treatment Breast OncologyMedicinePathologyBreast CancerCancer Treatment	2015	70

Page 1